# Extended Longevity, Inc.

Extended Longevity - Phytotherapeutic Antiaging Formulation Protocol.

## Elevator pitch
Extended Longevity develops and produces anti-aging natural products to decelerate the biomarkers of aging.

- Canonical URL: https://wefunder.com/extended.longevity.inc
- Entity ID: wefunder:company:102221
- Last updated: 2026-06-11T23:52:01Z
- Generated at: 2026-06-12T03:35:14Z

## Quick facts
- The Extended Longevity Protocol is a tested way to decelerate the biomarkers of aging.
- The Products are in production and currently selling. Operational facilities on Maui, HI.
- Seasoned Management has taken 3 Companies public for successful exits.
- Epigenome tests show age deceleration of 16 years in a 70 year old man, 12 years in a 58 year woman.
- Telomere tests show regrowth of telomeres to that of a newborn-10,380 bp in a 70 year old man.
- The Extended Longevity Protocol is patent pending at the USPTO
- We have completed our first clinical study with outstanding results.
- Because of GRAS standing the Extended Longevity Protocol is available today.

## Active fundraises
- wefunder:fundraise:105179: 4(a)(6) open (USD)
- wefunder:fundraise:54337: 4(a)(6) successful (USD)
- wefunder:fundraise:54338: 4(a)(6) successful (USD)

## Story
The dream of every generation, since the dawn of time, is to turn back the clock and experience a youthful vitality. As each wave of humanity enters their “golden” years, explorers and scientists alike search for the proverbial “Fountain of Youth”. Appearing in the writings of Herodotus (5th century BC) and the Spanish explorer Juan Ponce de León and noted in the life of Methuselah whose age was “nine hundred sixty-nine years; and he died. 5:21–27”, many have tried. However, this holy grail of immortality has been elusive…until now! Now there is Extended Longevity.We are programed at the molecular level to experience diminished physiological functionality, a time sequenced debilitation followed by degeneration and increased mortality.  Now, we have come to understand this program is multi-faceted and called the 10 Determinant Factors of Aging. We know what they are, we know how they function, we know how to measure them, and for the first time in human history we know we can reverse them.There is now a broad scientific consensus that aging is primarily a degenerative process that is controlled by time-sequenced internal biological clocks, whose effects are felt as we age, across the human organism, and by systemic and cellular reactions to internal conditions. The known biological aging clocks controlling organism-wide functionality that diminish with age are:Pineal gland/ Hypothalamus/ Pituitary/ SCN axis disregulation; Production of NAD attenuation (essential in the production of ATP, the energy-releasing molecule);Thymic involution;Blood transcription signaling ratios,Telomere attrition; andEpigenetic cytosine methylation.Systemic mechanisms indicated as sources in the regulation of aging include:Cellular senescence;Stem cell exhaustion;Inflammation (and its effect on aging, the so-called "inflammaging" process); andExtra-Cellular Matrix stiffening.Aging is a universal feature of life, ranging from unicellular microorganisms to humans. Longevity depends on the maintenance of cellular functionality, and on the organism’s ability to respond to stress. Lifespan is also regulated by genes controlling the activity of metabolism, antioxidant systems, DNA repair, cellular senescence, and cell death. Their functions gradually decline due to random errors in DNA replication and damage to macromolecules, which leads to the accumulation of senescent cells and damaged tissue with age. Various signs of aging have also been linked to genomic instability and have indicated the role of DNA damage accumulation in the aging process and the development of age-related diseases, including heart disease, cancer, diabetes, Alzheimer's disease, and the autoimmune diseases.Aging is a continuation of a timed growth development program evolving into a phase of late-life self-annihilation. The body adapts to a variety of environmental stresses. These stresses may affect the adaptive responses of specific cellular processes and create resistive strengthening leading to increased longevity. The tendency of the organism to rebalance toward homeostasis is a biological response to both environmental and internal organic conditions that are determined by behavioral processes such as diet, stress, and activity, but can also be affected by certain drugs and/or herbal interventions.We live in an age of incredible scientific discovery, especially in the human biological sciences. Although new research into the field of anti-aging appears in scientific journals on a regular basis, we find ourselves on the cutting edge of a new understanding that may unlock the keys to life extension. In fact, the integration of this new research is the foundation of a new understanding we call: “Extended Longevity”. Although aging is common among almost all multicellular organisms, there are exceptions. The existence of species with an observable extended time-dependent functional decline, termed ‘negligible senescence’, suggests that the aging process can be affected by both internal and external conditions, which may lead to a modification of the aging process. In order to address these conditions of aging Extended Longevity has developed ten (10) synergistic and mimetic herbal analog formulations. They include:Pinetonal™ - is a Pineal Gland supporting formulation of six (6) plant species known to increase melatonin, pineol, zinc, and selenium, included are phytotherapeutic extracts of Pistacia vera, Scutellaria baicalensis, Passiflora incarnata, Panax quinquefolius, Elitaria cardamomum, and Cinnamomum verum.Thyvolve™ - is designed for regenerating the Thymus Gland and reversing the age-dependent process of Thymus involution. It consists of six (6) phytotherapeutic extracts including Selaginella involvens, Pinus sylvestris (Pollen), Curcuma longa, Zingiber officinale, Elitaria cardamomum, and Cinnamomum verum.Bluecosig™  Formula is designed for blood signaling and transcription adjustment, for aging reversal or rejuvenation via blood signaling to all cells. It contains phytotherapeutic extracts of Caulophyllum thalictroides, Panax quinquefolius, Scutellaria baicalensis, and Curcuma longa.Telogenic™  Longevity Formula is a phytotherapeutic extract of three (3) synergistic herbal analogs, including Astragalus membranaceus, Centella asiatica, and Salix Alba. It is a telomerase-creating natural plant extract that stops the degradation of telomeres and rebuilds them, reversing cell loss from telomere attrition.Sentophagy™ - is a phytotherapeutic extraction of five (5) plant species known to induce autophagy and mitophagy, including Taraxacum officinale, Camellia senensis, Berberis vulgarus, Curcuma longa, and Cinnamomum verum.Inflasolve™ - is formulated to reduce systemic inflammation that is a root cause of aging (called “Inflammaging”). It contains phytotherapeutic extracts of Curcuma longa, Boswellia sacra, Salix alba, Camellia sinensis, and Cinnamomum verum.Stemegenis ™ - is designed to regenerate active stem cells from the age-dependent condition called “stem cell exhaustion,” reversing it. It contains phytotherapeutic extracts of Garcinia indica, Astragalus membracanus, and Cinnamomum verum.CMEnhance™ - is designed to support Cellular Metabolic Efficiency, increasing Resveratrol, Sirtuins, NAD, NMN and contains phytotherapeutic extracts of Polygonum cuspidatum, Scutellaria baicalensis, Tabebuia avellanedae, Curcuma longa, and Cinnamomum verum.Epiverse™ - is an Epigenetic Clock reversing (DNAm, cytosine methylation) synergistic herbal analog formulation of six (6) plant species. Included are phytotherapeutic extracts of Berberis vulgaris, Pinus sylvestris (Pollen), Lepidium meyenii, Taraxacum officinale, Elitaria cardamomum, and Cinnamomum verum.Elastage ECM™ - Elastic fibers, composed of an elastin core (90%) surrounded by fibrillin-rich microfibrils (10%), are essential extracellular matrix (ECM) macromolecules endowing extensible tissues with critical mechanical properties such as resilience, flexibility, and elasticity. The cross-linking theory of aging states that aging results from the accumulation of intra-intermolecular crosslinks between molecules with slow turnovers, such as collagen and elastin of the extracellular matrix (ECM).Extended Longevity Time LineContact Us*None of these statements have been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.Disclaimer: The entire contents of this campaign page are the opinion of Extended Longevity, Inc. They are not intended to replace a one-on-one relationship with a qualified health care professional, and they are not intended as medical advice. They are intended as a sharing of knowledge and information from the research and experience of Extended Longevity, Inc. Extended Longevity, Inc. encourages you to make your own health care decisions based on your research and in partnership with a qualified health care professional.All material provided from Extended Longevity is for informational or educational purposes only. Consult a physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition. The instructions and advice presented from Extended Longevity are in no way intended as medical advice or a substitute for medical counseling. The information should be used in conjunction with the guidance and care of your physician. Consult your physician before beginning this program. Your physician should be aware of all medical conditions you may have, as well as medications and supplements you are taking. If you are on diuretics or diabetes medication, have liver or gallbladder disease, take medications, or have other health concerns, please proceed only under a doctor’s supervision. This program should not be used by patients on dialysis or by women who are pregnant, nursing, or trying to conceive. You must be at least 30 years of age to do the Extended Longevity Program.

## FAQ
1. **I'm not skeptical about the concept -- as a Yale undergrad in Molecular Biophysics and Biochemistry, I've been "doing best age reversal practices" for close to a decade, and I've SEEN results in my DNA and blood work. I'm skeptical about the company -- need to see FAR more det...**
   - Hi Frederic, In the limited space provided by Wefunder we strive to provide as much pertinent information as possible. In order to achieve a a 10x in MOIC over 3 years or less, an aggressive company needs proper capitalization, hence the Wefunder campaign. We have concentrated our efforts on the science of longevity, product development and biomarker testing of a small cohort, with extraordinary success. Our sales are now in play and growing and our market vast. In the USA alone, the census i...
2. **In your "Going to the Market"-Strategy you mentioned David Sinclair and Tony Robbins. How far are you with your negotiations with them?**
   - Hi Martin, I have sent feelers out to David Sinclair with no response thus far. As to Tony Robbins we have sent a set of the Extended Longevity Protocol to him through a direct contact associate. Awaiting his response.
3. **Hello, I saw that in your current study, you have excluded a lot of people that would benefit the most with the Extended Longevity program. What are the reasons for that? Although I think that it is great that Mr. Schorr possibly has increased his telomeres from 9.01kb to 9.30...**
   - Hello Miguel, We have not excluded anyone from the study, but have defined the study to include a cohort of people in the ages of 55 to 75, which we believe is the most appropriate age for the study. You are incorrect about the regrowth of telomeres for Mr. Schorr. Yes, he has regrown telomeres to 9,050 base pairs, the equivalent of a 10 year old, which is amazing for a 69 year-old man. Unfortunately, he did not have a baseline test for his telomeres. - Ingredients are sources from reputable ...
4. **We want to know what you see your valuation will look like in 3 years also the income and balance statements Not to say much, I think we are very much interested in this project but then we are not opting for the crowdfunding route. We were wondering if you have provisions to ...**
   - Thomas, Thank you for your interest. We continue to have excellent success with our program to reverse the biomarkers of aging. I just turned 70 and yet have the telomeres of a newborn, having regrown them to 10,380 base pairs. I have maintained my epigenome at 54, for 3 years, thus stopping aging and the new GlycanAge test says I'm 32! Perhaps now is the time to take a fresh look at Extended Longevity!

## Team
- Steven M. Schorr (Founder & CEO and CSO)
- Hamiel O. Schorr (COO & Director)
- Mark Matthews (CMO)

## Q&A
- Q: I'm not skeptical about the concept -- as a Yale undergrad in Molecular Biophysics and Biochemistry, I've been "doing best age reversal practices" for close to a decade, and I've SEEN results in my DNA and blood work. I'm skeptical about the company -- need to see FAR more detail about their sales and expenses history given their lofty $45M valuation. I only invest in startups where I see a decent chance of a 10x in MOIC over 3 years or less, and I'm doing quite well across my 100+ deal portfolio, thank you very much. (Helps to have an MBA in Investment Finance from Berkeley...)
  - A: Hi Frederic, In the limited space provided by Wefunder we strive to provide as much pertinent information as possible. In order to achieve a a 10x in MOIC over 3 years or less, an aggressive company needs proper capitalization, hence the Wefunder campaign. We have concentrated our efforts on the science of longevity, product development and biomarker testing of a small cohort, with extraordinary success. Our sales are now in play and growing and our market vast. In the USA alone, the census info has 75 million between 55-75 with a $75K income. At a 1% sale rate we look to 750,000 customers at $400 per month which, will produce revenue of $300MM per month or $3.6B per year. You think we can justify a $45M evaluation?
- Q: We want to know what you see your valuation will look like in 3 years also the income and balance statements Not to say much, I think we are very much interested in this project but then we are not opting for the crowdfunding route. We were wondering if you have provisions to accept alternative financing which should save time of WAITING SO LONG for your target to be met. With that we can cover over 50% of your target raise. Kindly reach out to me at thomas@700capital.se so we discuss further.
  - A: Thomas, Thank you for your interest. We continue to have excellent success with our program to reverse the biomarkers of aging. I just turned 70 and yet have the telomeres of a newborn, having regrown them to 10,380 base pairs. I have maintained my epigenome at 54, for 3 years, thus stopping aging and the new GlycanAge test says I'm 32! Perhaps now is the time to take a fresh look at Extended Longevity!
- Q: Hello, I saw that in your current study, you have excluded a lot of people that would benefit the most with the Extended Longevity program. What are the reasons for that? Although I think that it is great that Mr. Schorr possibly has increased his telomeres from 9.01kb to 9.30kb, the increase is about 3%. With the average test having a 5% margin of error (I don't know the specific test, biological assay, possible machine used, etc... intrinsic margins of error), this result could be not statistically significant. About the products and as I visited your website (quite clunky when used on Android), I have a few questions: - How are the ingredients sourced and manipulated? - Do you use a 3rd party independent lab to verify/test your products parameters? - This question is kind of a continuation from the previous one. As the product is a liquid -and depending upon a test being performed per lot/batch- what is the "recommended daily amount" for your product? I haven't seen a described amount to be taken in your website. - Why the product is a liquid? I think that it would be more advantageous -and possibly decrease expenses- if certain ingredients were given in a grinded form and let the customer brew their own liquid with instructions. I believe that in Asian countries this type of medicine is still in use. Best regards, Miguel Costa
  - A: Hello Miguel, We have not excluded anyone from the study, but have defined the study to include a cohort of people in the ages of 55 to 75, which we believe is the most appropriate age for the study. You are incorrect about the regrowth of telomeres for Mr. Schorr. Yes, he has regrown telomeres to 9,050 base pairs, the equivalent of a 10 year old, which is amazing for a 69 year-old man. Unfortunately, he did not have a baseline test for his telomeres. - Ingredients are sources from reputable companies for their Organic and traceable constituency. - No we rely on traceability and providence of our extraction process. - We recommend 1 ml per day per product (there are 10 in the protocol) - Liquid extracts have the best bioavailability. Best regards
- Q: In your "Going to the Market"-Strategy you mentioned David Sinclair and Tony Robbins. How far are you with your negotiations with them?
  - A: Hi Martin, I have sent feelers out to David Sinclair with no response thus far. As to Tony Robbins we have sent a set of the Extended Longevity Protocol to him through a direct contact associate. Awaiting his response.